Ellis Brian W

SVP-GC Ellis sells 21,776 shares ($4.8M) at $219.21–$219.23; held 36,329 pre-sale, down 59.9%

Ellis Brian W, Senior Vice President and General Counsel, executed 2 separate sales totaling 21,776 shares for $4,773,863.14 on 2025-11-12 at prices $219.21–$219.23, reducing his holdings from 36,329 to 14,553 shares (a -59.9% reduction). At DHR's current price of $221.20, the blended sale price of $219.23 was only $1.97 below market. His prior trades at DHR show mixed timing: 2 of 3 prior sells had negative 90-day returns (sales on 2025-01-30 and 2024-07-25 preceded declines), suggesting modest success identifying inflection points at this ticker, though the most recent prior sale on 2024-04-24 had a +5.7% 90-day return. The stock is currently +7.3% over 30 days and +4.9% over 90 days, trading -11.7% from its 52-week high of $250.59; fundamentals show DHR at a P/E of 44.60 with flat annual revenue growth (-0.1%) and modest net income of $908 million on $6.1B quarterly revenue. The material reduction in Holmes' own position warrants observation of whether further insider activity follows in the near term.

GC Ellis Brian W sold 5,700 DHR shares at $224.13 (Jan 30); stock now $222.74, down 20.7% from 52-week high.

Ellis sold 5,700 shares for $1,277,541.00 on 2025-01-30, reducing holdings by 22.0% to 20,230 shares. The stock has declined 20.7% from its 52-week high and fallen 3.0% in the 30 days and 10.1% in the 90 days since the transaction. His prior trades at DHR showed mixed timing: a July 2024 sell preceded a 90-day decline of 7.0% (well-timed), while an April 2024 sell preceded gains of 5.7% (poorly timed). At the cross-ticker level, his track record spans only 2 prior sells with a 50.0% well-timed rate at 90 days. The company's fundamentals show annual revenue growth of -24.1%, a P/E of 41.32, and most recent quarterly revenue of $5,798,000,000.00 with net income of $818,000,000.00. The sale occurred in a context of elevated valuation and declining growth, though the relatively modest share reduction (22% of prior holdings) and retention of 20,230 shares suggest continued material exposure to the firm.

GC Ellis sells 9,600 DHR shares at $275.16; holdings fall to 20.2K from 29.8K (-32.2%). Stock near 52-week high.

Ellis Brian W, Senior Vice President and General Counsel, sold 9,600 shares (32.2% reduction from his pre-transaction holdings of 29.8K shares) at $275.16, with the current price at $273.91 near the 52-week high of $273.91. His cross-ticker track record shows only 1 prior sell with a 90-day return of +5.7%, and his one prior DHR transaction (a sell on 2024-04-24) also returned +5.7% over 90 days—both outcomes where the stock rose after his sales, indicating poorly timed exits relative to subsequent price appreciation. The stock is up 8.0% over 30 days and 11.1% over 90 days, and DHR trades at a P/E of 47.06 with annual revenue growth of -24.1%, suggesting elevated valuation amid declining top-line momentum.